EMJ Diabetes最新文献

EMJ Diabetes Pub Date : 2023-11-16 DOI: 10.33590/emjdiabet/10307138

Natasha Meunier-McVey

引用次数: 0

Equity Versus Equality: A Spotlight on Health Inequalities 公平与平等：聚焦健康不平等

EMJ Diabetes Pub Date : 2023-11-16 DOI: 10.33590/emjdiabet/10303633

Anaya Malik

引用次数: 0

Satisfaction with Home Healthcare Provider Service in Adults with Type 1 Diabetes Using a Hybrid Closed Loop System: The SATURN Study 使用混合闭环系统的 1 型糖尿病成人患者对家庭医疗服务提供者服务的满意度：SATURN 研究

EMJ Diabetes Pub Date : 2023-11-16 DOI: 10.33590/emjdiabet/10303508

H. Hanaire, Nicolas Naiditch, V. Melki, Pierre Morcel, Nelly Puech, Emeric Scharbarg, Raquel Tirado-Godas, Guila Lancman, M. Schaller, Cécile Delval, Lucy Chaillous

{"title":"Satisfaction with Home Healthcare Provider Service in Adults with Type 1 Diabetes Using a Hybrid Closed Loop System: The SATURN Study","authors":"H. Hanaire, Nicolas Naiditch, V. Melki, Pierre Morcel, Nelly Puech, Emeric Scharbarg, Raquel Tirado-Godas, Guila Lancman, M. Schaller, Cécile Delval, Lucy Chaillous","doi":"10.33590/emjdiabet/10303508","DOIUrl":"https://doi.org/10.33590/emjdiabet/10303508","url":null,"abstract":"Introduction: Hybrid closed loop (HCL) systems have the potential to improve glycaemic control in people with Type 1 diabetes (T1D). In France, patient technical education and assistance for HCL users is provided by trained nurses from home healthcare providers (HHP). The objective of this study was to evaluate satisfaction of people with T1D with HHP services. Methods: In total, 35 participants with T1D and a prescription for an HCL system were studied during 3 months after HCL initiation in two French hospitals. A series of questionnaires were completed by participants. The number of planned (per protocol) and unplanned HHP interactions was monitored. Glycaemic control at inclusion and Day 90 was compared; formal statistical testing was carried out post-hoc. Results: Client Satisfaction Questionnaire (CSQ-8) with HHP service was high both at Day 30 (mean CSQ-8 score: 28.9; 95% confidence interval [CI]: 28.0; 29.9) and at Day 90 (29.0; 95% CI: 27.9; 30.0). Hypoglycemia Fear Survey-II (HFS-II) score (standard deviation) decreased from 31.2 (±15.7) at inclusion to 23.1 (±16.8) at Day 90. Participants had a median number of four home visits and two phone calls, but important differences were observed between participants: total interactions with HHP nurses ranged between five and 12 contacts, and 45.7% of participants requested unplanned interactions. Glycaemic control improved significantly: mean time in range increased from 57.0% (±13.3) at inclusion to 71.4% (±9.4) at Day 90 (p<0.001). Conclusion: HHP services for early phase HCL implementation were met with high client satisfaction levels. Study results emphasise the need for a personalised HHP approach.","PeriodicalId":418035,"journal":{"name":"EMJ Diabetes","volume":"85 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139269736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Preconception Care for Individuals with Diabetes 糖尿病患者的孕前保健

EMJ Diabetes Pub Date : 2023-11-16 DOI: 10.33590/emjdiabet/10305435

S. M. Mukherjee, Aimee Dawson, Katherine M Carey

{"title":"Preconception Care for Individuals with Diabetes","authors":"S. M. Mukherjee, Aimee Dawson, Katherine M Carey","doi":"10.33590/emjdiabet/10305435","DOIUrl":"https://doi.org/10.33590/emjdiabet/10305435","url":null,"abstract":"The incidence of diabetes has been increasing and, in parallel, so has the incidence of females in their childbearing years with diabetes. Preconception care is important in females with diabetes due many factors related to fertility, blood glucose control, and complications. For example, many individuals with Type 2 diabetes are obese, which can affect contraceptive efficacy, fertility, and fetal growth. Additionally, patients with all types of diabetes are at risk for disordered eating, which can be harmful to a developing fetus. Both hypoglycaemia and hyperglycaemia are known to increase the risk of adverse maternal and neonatal outcomes, including during the first trimester, when many females are not aware of pregnancy. Additionally, individuals with diabetes are at risk for complications, such as atherosclerotic cardiovascular disease, nephropathy, retinopathy, and neuropathy, that can lead to complicated pregnancies. Importantly, several of the medications used to control blood glucose, and manage diabetes complications, are not recommended for use during pregnancy due to potential fetal harm. For these reasons, females with diabetes in their childbearing years are encouraged to utilise reliable contraception, so that pregnancies can be planned, or should be treated with medications with low teratogenicity potential. Thus, the preconception care of females with diabetes is complex, and the increasing prevalence of this patient population warrants greater awareness among clinicians. This narrative review summarises the current standard of preconception care for individuals with diabetes, including the management of contraception, weight, blood glucose, hypertension, and dyslipidaemia.","PeriodicalId":418035,"journal":{"name":"EMJ Diabetes","volume":"9 1-2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139267386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Mean Platelet Volume in Type 2 Diabetes: Correlation with Poor Glycaemic Control 2 型糖尿病患者的平均血小板体积：血糖控制不佳的相关性

EMJ Diabetes Pub Date : 2023-11-16 DOI: 10.33590/emjdiabet/10309803

Avarna Agarwal, Anita Arya, R. Saxena, Simmi Dube

{"title":"Mean Platelet Volume in Type 2 Diabetes: Correlation with Poor Glycaemic Control","authors":"Avarna Agarwal, Anita Arya, R. Saxena, Simmi Dube","doi":"10.33590/emjdiabet/10309803","DOIUrl":"https://doi.org/10.33590/emjdiabet/10309803","url":null,"abstract":"Background: Diabetes is a global pandemic. Mean platelet volume (MPV) is an indicator of increased platelet activity, which is considered to play a role in the development of vascular complications in diabetes. Platelet volume is strongly and independently related with glycaemic control in Type 2 diabetes (T2D). Aim: To study the MPV in patients with T2D, and its correlation with HbA1c, duration of T2D, and microvascular complications. Methodology: This was a cross-sectional, observational study conducted at the Department of Medicine, Gandhi Medical College, Bhopal, India, during a period of 18 months on 300 patients with T2D. Blood glucose, HbA1c, MPV, fundoscopy, and 24-hour urine protein were done. Data were represented as mean+/-standard deviation and statistical analysis was done using SPSS software (IBM, Armonk, New York, USA). Results: The mean age of patients was 56.64±8.69 years, with 52% of the patients being females. Of these patients, 18.3% had HbA1c between 6.5–8.0%, 51.7% between 8.1–10.0% and the rest above 10.0%. A total of 51% of the patients had diabetes for 6–10 years of duration and 30% for more than 10 years. Patients with higher HbA1c level and prolonged duration of diabetes had higher MPV (p<0.001). Patients with advanced diabetic retinopathy changes and nephropathy also had higher MPV (p<0.05). Conclusion: Measurement of MPV in patients with T2D can be a useful and easily available prognostic marker, and hence assist clinicians to anticipate the occurrence of microvascular complications associated with the disease, especially in resource-poor settings, and reduce the burden of cost for the patient.","PeriodicalId":418035,"journal":{"name":"EMJ Diabetes","volume":"111 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139267888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

EASD 2023 Abstract Highlights EASD 2023 摘要集锦

EMJ Diabetes Pub Date : 2023-11-16 DOI: 10.33590/emjdiabet/10301251

引用次数: 0

Review of the 59th European Association for the Study of Diabetes (EASD) Annual Meeting 第 59 届欧洲糖尿病研究协会 (EASD) 年会回顾

EMJ Diabetes Pub Date : 2023-11-16 DOI: 10.33590/emjdiabet/10308765

引用次数: 0

Hidden Complication of Obesity and Diabetes: Is It Time to Put More Focus on Fatty Liver? 肥胖和糖尿病的隐藏并发症：是时候更加关注脂肪肝了吗？

EMJ Diabetes Pub Date : 2023-11-16 DOI: 10.33590/emjdiabet/10307262

James Woijoo Kim, Giada Sebastiani

{"title":"Hidden Complication of Obesity and Diabetes: Is It Time to Put More Focus on Fatty Liver?","authors":"James Woijoo Kim, Giada Sebastiani","doi":"10.33590/emjdiabet/10307262","DOIUrl":"https://doi.org/10.33590/emjdiabet/10307262","url":null,"abstract":"Since the release of the EMPA-REG trial in 2015, the focus in diabetes management has been shifted from a glucocentric approach to a more organ-protective approach. Much of the focus has been on cardiorenal protections, thanks to the numerous landmark trials being published in recent years. However, the significance of what seems to be an innocuous fatty deposition in the liver has received less attention than it deserves for many years, especially in people living with diabetes and obesity, but its impact on health has slowly been highlighted more in the last decade. Bodies of research are now suggesting that non-alcoholic fatty liver disease (NAFLD) is a significant independent risk factor for cardiovascular disease, including myocardial infarction, heart failure, and atrial fibrillation, while it carries the increased risk of cirrhosis, hepatocellular carcinoma, and extrahepatic cancers. Numerous organisations have begun to publish guidelines focusing on screening and treating NAFLD in recent years in an effort to combat this underappreciated, underdiagnosed, and undertreated complication of diabetes and obesity. This review paper will provide an overview of NAFLD, highlighting the argument that NAFLD is indeed an independent cardiovascular risk factor, discussing the proposed pathophysiology of NAFLD being a cardiovascular risk factor, and suggesting a highly validated hepatic fibrosis screening tool, which is a simple, easy-to-use tool to screen for hepatic fibrosis, and can be used in primary care offices.","PeriodicalId":418035,"journal":{"name":"EMJ Diabetes","volume":"40 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139267590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Diabetic Peripheral Neuropathy: The Forgotten Complication of Diabetes 糖尿病周围神经病变:被遗忘的糖尿病并发症

EMJ Diabetes Pub Date : 2023-09-06 DOI: 10.33590/emjdiabet/10303408

Viatris

引用次数: 0

Newer Oral Levothyroxine Formulations: Is It Time to Switch Over? 新的口服左甲状腺素制剂:是时候更换了吗?

EMJ Diabetes Pub Date : 2023-01-30 DOI: 10.33590/emj/10306765

V. Rajkumar

引用次数: 0